Verification Pending — official Grants.gov candidate (posted)
RFA-DA-26-034
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
Official Grants.gov opportunity RFA-DA-26-034 from National Institutes of Health. Requires full eligibility, amount, controlling deadline, award-type and duplication QA before publication.
FundingOfficial federal synopsis lists an award ceiling of 300,000; applicant-level applicability requires full-NOFO review.
Deadline2027-11-18 (official deadline clock time and time zone must be checked in NOFO)
Last verifiedAtlas review
Required next actionReview the official full announcement, amendments and submission portal requirements before applying.
Broad Eligibility
Others (see text field entitled "Additional Information on Eligibility" for clarification); Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; State governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Special district governments; Private institutions of higher education; For profit organizations other than small businesses; County governments; City or township governments; Small businesses; Independent school districts; Native American tribal organizations (other than Federally recognized tribal governments); Public and State controlled institutions of higher education; Native American tribal governments (Federally recognized); Public housing authorities/Indian housing authorities
Official funding announcement — preliminary draft
Funder: National Institutes of Health
Opportunity number: RFA-DA-26-034
Official listed status: posted
Closing information: 2027-11-18 (official deadline clock time and time zone must be checked in NOFO)
Award disclosure: Official federal synopsis lists an award ceiling of 300,000; applicant-level applicability requires full-NOFO review.
Applicant categories in federal synopsis: Others (see text field entitled "Additional Information on Eligibility" for clarification); Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; State governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Special district governments; Private institutions of higher education; For profit organizations other than small businesses; County governments; City or township governments; Small businesses; Independent school districts; Native American tribal organizations (other than Federally recognized tribal governments); Public and State controlled institutions of higher education; Native American tribal governments (Federally recognized); Public housing authorities/Indian housing authorities
Federal synopsis
This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support research on the persistent and/or delayed pathophysiological effects after acute exposure to such agents.
Draft intake record. Eligibility, program terms, current amendments and applicant ceiling must be independently verified before publishing.
Official Grants.gov opportunity and NOFO
From Funding to Implementation · School Health Solution
Turn school-health funding into a clinically capable care model.
Dr. Miltie N9+ can support clinician-directed remote exams in school settings, helping care teams move beyond video-only encounters when a funded program calls for stronger pediatric access.
Source verificationOfficial government source · www.grants.govAtlas last verified this record during its latest review. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗
